Amoxicillin And Clavulanate Potassium
Product Images NDC 61919-019

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 61919-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

61919 0019 20

61919 0019 20
AMOXICILLIN AND CLAVULANATE POTASSIUM 500 mg/125 mg film-coated tablets packaging label from DIRECT RX. The label indicates 20 tablets per bottle and states the product is a generic version of Augmentin containing 500 mg amoxicillin and 125 mg clavulanic acid as potassium clavulanate. Includes lot number, expiration date, NDC code, and packaging location information.*
FDA Label Image

61919 0401 32

61919 0401 32
Label for AMOXICILLIN ORAL SUSP 400 mg/5 mL, 100 mL bottle by DIRECT RX. The label states the product is a generic for AMOXIL and contains amoxicillin trihydrate equivalent to 400 mg anhydrous amoxicillin per 5 mL dose. It includes instructions to discard after 40 days and contains packaging and distribution information for Alpharetta, GA.*
FDA Label Image

Image Description (Module)

Image Description (Module)
Chemical structure diagram showing the molecular structure of the active ingredients in Amoxicillin and Clavulanate Potassium, including labeled atoms and bonds for key functional groups.*
FDA Label Image

Image Description (Table)

Image Description (Table)
The image shows two data tables summarizing Helicobacter pylori eradication rates with Amoxicillin as part of dual and triple therapy regimens. Each table compares the evaluable analysis and intent-to-treat analysis results for two studies, including 95% confidence intervals and patient numbers. Footnotes explain analysis criteria related to duodenal ulcers and H. pylori infection confirmation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.